Colorectal Cancer (CRC) Unknown Status Phase 2 Trials for Oxaliplatin (DB00526)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Unknown Status	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05480280	mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer	Treatment	Dalpiciclib (DB17456) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT03126071	Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer	Treatment	Bevacizumab (DB00112) Irinotecan (DB00762) Oxaliplatin (DB00526) Raltitrexed (DB00293)
NCT05588297	Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Nivolumab (DB09035) Oxaliplatin (DB00526)
NCT04324476	A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Irinotecan (DB00762) Oxaliplatin (DB00526)
NCT04301557	PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526) Toripalimab (DB15043)
NCT02529774	Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer	Treatment	Capecitabine (DB01101) Dexamethasone (DB01234) Floxuridine (DB00322) Heparin (DB01109) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT06206096	PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT06120127	Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526) Sintilimab (DB15765)
NCT05839470	Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer	Treatment	Bevacizumab (DB00112) Cadonilimab (DB16680) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05435313	Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy	Treatment	Fruquintinib (DB11679) Irinotecan (DB00762) Oxaliplatin (DB00526) Raltitrexed (DB00293) Tislelizumab (DB14922)
NCT01515787	PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05871333	Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients	Prevention	Fluorouracil (DB00544) Leucovorin (DB00650) Losartan (DB00678) Oxaliplatin (DB00526)
NCT00072553	Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer	Treatment	Celecoxib (DB00482) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01802645	Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT06003998	Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab	Treatment	Bevacizumab (DB00112) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT06010888	Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC	Treatment	Fluorouracil (DB00544) Fruquintinib (DB11679) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT03280407	NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer	Treatment	Capecitabine (DB01101) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00997685	Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT00006115	Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05200299	mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02415699	DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00513266	Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05340231	An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT04668976	A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma	Treatment	Cetuximab (DB00002) Floxuridine (DB00322) Fluorouracil (DB00544) Gemcitabine (DB00441) Irinotecan (DB00762) Oxaliplatin (DB00526) Panitumumab (DB01269)
NCT01196260	Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Oxaliplatin (DB00526)
NCT01384994	Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients	Treatment	Folic acid (DB00158) Oxaliplatin (DB00526) Panitumumab (DB01269)
NCT03748680	IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer	Treatment	Oxaliplatin (DB00526)
NCT02415829	Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT03711240	The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases	Treatment	Bevacizumab (DB00112) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00884767	Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00274872	Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01529164	Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer	Treatment	Endostatin (DB06423) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00408551	Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver	Treatment	Floxuridine (DB00322) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05511051	A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy	Treatment	Fluorouracil (DB00544) Fruquintinib (DB11679) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01628211	Second Look Laparoscopy in Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00438737	Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02942706	Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02515734	A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00647530	Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Oxaliplatin (DB00526) Panitumumab (DB01269)
NCT01097265	Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery	Diagnostic	Capecitabine (DB01101) Oxaliplatin (DB00526)
NCT01679327	Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT04653480	Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC	Treatment	Irinotecan (DB00762) Oxaliplatin (DB00526) Surufatinib (DB15106) Toripalimab (DB15043)
NCT00383695	Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer	Treatment	Capecitabine (DB01101) Cetuximab (DB00002) Oxaliplatin (DB00526)
NCT05524155	Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526) Regorafenib (DB08896) Sintilimab (DB15765)
NCT02688023	Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)